Addressing weight gain in smoking cessation treatment: a randomized controlled trial
Terry Bush1, Michele D Levine, Laura A Beebe
1Alere Wellbeing, Seattle, Washington, USA. Terry.Bush@alere.com
Purpose:
To evaluate the effectiveness of a cognitive behavioral treatment (CBT) addressing cessation-related weight concerns delivered via a tobacco quitline that does not address weight concerns.
Design:
Randomized controlled trial, blinded 6-month follow-up.
Setting:
The Oklahoma Tobacco Helpline (OKHL).
Subjects:
All 7998 smokers who called the OKHL were screened; 4240 were eligible; 2000 were randomized to the standard quitline (STD) or the brief version of the CBT weight concerns program (WCP).
Intervention:
Telephone counseling to help people quit smoking and address concerns about cessation-related weight gain.
Measures:
Demographics, weight, tobacco status, weight concerns, self-efficacy in quitting, and quitting without weight gain.
Analysis:
Descriptive statistics and logistic regression.
Results:
Of those randomized, 1002 participants completed the 6-month survey (response rates = 53.2% for STD, 47% for WCP). Compared with STD, WCP led to reduced weight concerns (p < .01) and less weight gain among quitters (1.8 vs. -3.4 pounds; p = .01). Although not significant, participants in the WCP were more likely to report 30-day abstinence (33.3% vs. 36.8%, p = .24; intent to treat = 17.7 vs. 17.3).
Conclusion:
The WCP was successfully delivered via a quitline and resulted in improved attitudes about weight and decreased cessation-related weight gain without harming quit rates. Promotion of a quitline focused on addressing weight in conjunction with quitline treatment for smoking cessation may improve cessation and weight outcomes. Study limitations include use of self-report and survey response.
Related Concept Videos
Atherosclerosis III: Management
Drug Dosing: Obese Patients
Stress Prevention and Stress Management Techniques IV
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Dosage Regimens: Designs and Approaches

